To confirm the results obtained after siRNA-mediated SIRT1 and 2 silencing, NSCLC cell lines were treated with tnv-1, a SIRT1 and SIRT2 pharmacological inhibitor [19]. The gene discussed is SIRT2; the disease is non-small cell lung carcinoma.